Insider trading

Period: 120 months Stock: DNTH Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
17 Sep 2026
CARR EDWARD CHIEF ACCOUNTING OFFICER
Sold on a plan 5×
$2.03M 20,000 at 101.38
100%
Sold half or more
1 Sep 2026
Randhawa Simrat EVP, Head of R&D
Sold on a plan 3×
$2.46M 23,124 at 106.41
85.3%
Sold half or more
10 Aug 2026
Veness Adam M SVP, General Counsel and Sec.
Sold on a plan
$1.78M 16,167 at 110.38
100%
Sold half or more
7 Aug 2026
Veness Adam M SVP, General Counsel and Sec.
Sold on a plan 2×
$424.32K 3,833 at 110.70
100%
Sold half or more
17 Jun 2026
Veness Adam M SVP, General Counsel and Sec.
Sold on a plan 2×
$2.42M 30,000 at 80.80
100%
Sold half or more
1 Jun 2026
Randhawa Simrat EVP, Head of R&D
Sold on a plan 3×
$2.40M 26,530 at 90.62
86.9%
Sold half or more
12 Mar 2026
CARR EDWARD CHIEF ACCOUNTING OFFICER
Sold on a plan 5×
$3.56M 43,682 at 81.49
100%
Sold half or more
12 Mar 2026
Randhawa Simrat EVP, Head of R&D
Sold on a plan
$2.76M 33,830 at 81.48
100%
Sold half or more
14 Nov 2025
Randhawa Simrat EVP, Head of R&D
Sold on a plan
$4.16M 109,031 at 38.14
96.5%
Sold half or more
13 Nov 2025
Randhawa Simrat EVP, Head of R&D
Sold on a plan 3×
$3.22M 87,507 at 36.81
95.6%
Sold half or more
22 Sep 2023
Randhawa Simrat Chief Medical Officer
Bought
$26.40K 2,000 at 13.20
100%
+100% of stake
21 Sep 2023
Randhawa Simrat Chief Medical Officer
Bought
$26.40K 2,000 at 13.20
opened
First buy on file
16 Sep 2021
GARDNER JASON See Remarks
Sold, plan not stated
$96.51K 14,340 at 6.73
4.8%
16 Sep 2021
Deardorf Caren Chief Commercial Officer
Sold, plan not stated
$41.98K 6,238 at 6.73
31.2%
16 Sep 2021
Beetham Thomas W. See Remarks
Sold, plan not stated
$41.07K 6,103 at 6.73
30.5%
16 Sep 2021
Olson Lisa See Remarks
Sold, plan not stated
$38.60K 5,736 at 6.73
28.7%
16 Sep 2021
Mahoney Stephen F. See Remarks
Sold, plan not stated
$38.60K 5,736 at 6.73
28.7%
16 Sep 2021
Stants Kristen Chief People Officer
Sold, plan not stated
$38.60K 5,736 at 6.73
28.7%
16 Sep 2021
Nichols David Wayne Chief Technical Officer
Sold, plan not stated
$38.32K 5,694 at 6.73
28.5%
10 Jan 2020
GARDNER JASON See Remarks
Sold, plan not stated
$170.80K 11,200 at 15.25
4.3%
2 Jan 2020
DAVIS JOHN C. JR Chief Medical Officer
Sold, plan not stated
$169.82K 11,294 at 15.04
57.6%
Sold half or more
2 Jan 2020
GARDNER JASON See Remarks
Sold, plan not stated
$42.28K 2,800 at 15.10
1.1%
24 Dec 2019
ZDRAVESKI ZORAN See Remarks
Sold, plan not stated
$126.43K 7,902 at 16.00
5.8%
24 Dec 2019
ISACSON CHRISTINA K. Chief Business Officer
Sold, plan not stated
$71.45K 4,463 at 16.01
5.1%
23 Dec 2019
ISACSON CHRISTINA K. Chief Business Officer
Sold, plan not stated
$158.17K 9,867 at 16.03
10.1%
23 Dec 2019
ZDRAVESKI ZORAN See Remarks
Sold, plan not stated
$67.02K 4,181 at 16.03
3.0%
23 Dec 2019
GARDNER JASON See Remarks
Sold, plan not stated
$43.75K 2,897 at 15.10
1.1%
20 Dec 2019
GARDNER JASON See Remarks
Sold, plan not stated
$1.16M 76,711 at 15.16
22.2%
20 Dec 2019
DAVIS JOHN C. JR Chief Medical Officer
Sold, plan not stated
$13.79K 919 at 15.00
10.0%
10 Dec 2019
DAVIS JOHN C. JR Chief Medical Officer
Sold, plan not stated
$255.83K 17,055 at 15.00
67.3%
Sold half or more
10 Dec 2019
GARDNER JASON See Remarks
Sold, plan not stated
$66.32K 4,392 at 15.10
1.3%
9 Dec 2019
DAVIS JOHN C. JR Chief Medical Officer
Sold, plan not stated
$69.21K 4,614 at 15.00
35.7%
2 Dec 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated 3×
$97.52K 7,500 at 13.00
3.0%
20 Nov 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$60.00K 5,000 at 12.00
2.0%
1 Nov 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$53.33K 5,000 at 10.67
1.9%
1 Oct 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$50.06K 5,000 at 10.01
1.9%
19 Sep 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$19.87K 1,656 at 12.00
0.6%
12 Sep 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$10.13K 844 at 12.00
0.3%
3 Sep 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$50.53K 5,000 at 10.11
1.8%
1 Aug 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated 2×
$100.63K 7,500 at 13.42
2.7%
1 Jul 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated 2×
$107.98K 7,500 at 14.40
2.6%
21 Jun 2019
GARDNER JASON See Remarks
Sold, plan not stated
$186.32K 12,331 at 15.11
3.4%
21 Jun 2019
ISACSON CHRISTINA K. Chief Business Officer
Sold, plan not stated
$87.02K 5,415 at 16.07
5.2%
20 Jun 2019
GARDNER JASON See Remarks
Sold, plan not stated
$25.20K 1,669 at 15.10
0.5%
17 Jun 2019
COOKE MICHAEL P. Chief Scientific Officer
Sold, plan not stated
$104.27K 7,500 at 13.90
2.6%
25 Jun 2018
GARDNER JASON See Remarks
Bought
$6.00K 400 at 15.00
0.1%
First buy on file
Showing 1–46 of 46.